Publisher
Springer Berlin Heidelberg
Reference67 articles.
1. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. New England Journal of Medicine 1995; 333:1581–1587.
2. Hacke W, Kaste M, Fieschi C, et al. Randomised double blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute stroke (ECASS II). Lancet 1998; 352:1245–1251.
3. Wardlaw JM, Yamaguchi T, del Zoppo G. Thrombolytic therapy versus control in acute ischaemic stroke. Stroke module of the Cochrane Database of Systematic Reviews. Available in the Cochrane Library (database on disk and CDROM). Oxford: Update software, 1999.
4. Buchan AM, Pulsinelli WA. Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J Neurosci 1990;10:311–316.
5. Colbourne F, Li H, Buchan AM. Continuing post-ischemic neuronal death in CA1: Influence of ischemia duration, and cytoprotective doses of NBQX and SNX-111. Stroke 1999;30:662–668.